Gastroenterology Doctors in Berlin, MD Accepting Medicare

4 Gastroenterology doctors found. Showing 1 - 4

Jonathan D Bell, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 314 Franklin Ave, Suite 304, Berlin, MD 21811 Phone: 410-629-1450    Fax: 410-629-1460

Scott Louis Itzkowitz, D.O. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10614 Racetrack Rd Ste 5, Berlin, MD 21811 Phone: 410-629-1450    Fax: 410-629-1460

Lee Warren Klepper, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 314 Franklin Ave, Suite 304, Berlin, MD 21811 Phone: 410-629-1450    Fax: 410-629-1460

Jerrold S. Canakis, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10344 Old Ocn Blvd, Berlin, MD 21811 Phone: 410-641-2938    Fax: 410-641-4904

News Archive

BioNanomatrix awarded NIH grant for nanoscale platform for single-molecule DNA mapping

BioNanomatrix, Inc. has announced receipt of a grant from the National Human Genome Research Institute of the U.S. National Institutes of Health (NIH). Under the direction of BioNanomatrix principal investigator Dr. Ming Xiao, the two-year $399,020 project will develop a nanoscale platform for single-molecule haplotyping imaging and analysis of long strands of DNA at ultra-high resolution in a massively parallel format.

February issue of Chest releases latest medical news

Inhaled corticosteroids (ICS) are widely used for the treatment of chronic obstructive pulmonary disease (COPD). However, new research suggests that ICS may only provide a modest benefit in reducing exacerbations in patients with COPD.

Studies show HPV testing is more sensitive than current screening methods

The current technique for screening for cervical cancer involves collecting cells by way of a pap smear and examining them under a microscope. Although this method has reduced cervical cancer in countries where it is regularly used, it has several weaknesses.

NOXXON Pharma announces the successful completion of the first phase I trial of Spiegelmer NOX-E36

NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.

Read more Medical News

› Verified 3 days ago